avian
infecti
bronchiti
viru
ibv
group
iii
coronaviru
major
econom
impact
poultri
industri
infect
layer
often
larg
drop
egg
product
due
impair
ovari
oviduct
function
clinic
manifest
ibvinfect
chicken
includ
respiratori
renal
reproduct
diseas
often
coupl
secondari
infect
airsacul
oviduct
salping
although
etiolog
pathogenesi
diagnosi
describ
sinc
molecular
mechan
viral
entri
remain
elus
virus
util
variou
mechan
gain
entri
host
cell
envelop
virus
need
shed
viral
envelop
order
releas
genom
target
cell
initi
replic
process
uncoat
typic
follow
two
distinct
mechan
phdepend
fusion
endosom
phindepend
fusion
cell
surfac
mani
envelop
virus
eg
influenza
virus
util
variou
endocyt
pathway
travel
deep
cell
cytoplasm
order
smoothli
bypass
cortic
cytoskeleton
near
cell
peripheri
endocyt
pathway
also
provid
suitabl
acid
environ
phdepend
membran
fusion
deliv
viral
genom
cell
contrast
paramyxovirus
eg
sendai
virus
well
establish
enter
target
cell
via
phindepend
fusion
plasma
membran
coronavirus
contrast
result
report
regard
role
endosom
low
ph
activ
consequ
gener
consensu
regard
entri
mechan
major
characterist
ibv
infect
cell
format
larg
syncytia
becom
key
piec
evid
support
fusion
cell
plasma
membran
neutral
ph
viral
entri
model
phneutral
syncytia
format
thought
repres
model
coronaviru
fusion
entri
howev
electron
microscopi
patterson
et
al
clearli
show
ibv
enter
chorioallanto
membran
cam
chick
kidney
cell
via
viroplexi
cellular
engulf
cornel
univers
ithaca
new
york
victor
c
chu
lisa
j
mcelroy
damon
ferguson
cytoplasm
vacuol
addit
li
cavanagh
demonstr
ibv
strain
beaudett
ibvbdtt
infect
reduc
much
lysosomotrop
agent
ammonium
chlorid
recent
establish
tissu
cultur
system
use
ibvbdtt
virus
infect
babi
hamster
kidney
cell
use
monoclon
antibodi
label
studi
coronaviru
entri
requir
goal
investig
molecular
mechan
ibvbdtt
entri
found
ibv
infect
sensit
endocytosi
inhibitor
includ
monensin
chlorpromazin
dosedepend
manner
therefor
conclud
despit
syncytia
format
late
time
infect
ibv
strain
beaudett
util
endocyt
pathway
low
phinduc
fusion
gain
entri
cell
examin
rout
entri
ibvbdtt
viru
infect
made
use
ph
neutral
agent
monensin
ionophor
monensin
neutral
ph
gradient
endocyt
vesicl
exchang
lumin
proton
h
potassium
ion
k
henc
inhibit
low
ph
depend
viruscel
fusion
ibv
strain
beaudett
propag
cultur
allanto
fluid
specif
pathogen
free
spf
embryon
chicken
egg
sendai
viru
strain
cantel
atcc
also
propag
control
viru
standard
ibvbdtt
sendaicantel
infect
achiev
inocul
monolay
cell
atcc
moi
viru
bind
media
cellgro
contain
bovin
serum
albumin
cellgro
mm
hepe
cellgro
ph
tissu
cultur
treat
plate
viru
adsorb
co
free
incub
minut
gentl
rock
viral
inoculum
replac
dmem
infect
media
cellgro
contain
fetal
bovin
serum
cellgro
penicillin
streptomycin
cellgro
mm
hepe
cellgro
incub
resum
co
incub
addit
hour
cell
monolay
fix
icecold
methanol
sigma
minut
hour
postinocul
ibv
infect
identifi
use
monoclon
antibodi
chicken
polyclon
antisendai
viru
antibodi
usbiolog
use
identifi
sendai
viru
infect
secondari
antibodi
alexa
goat
antimous
antichicken
molecular
probe
cell
observ
nikon
eclips
fluoresc
microscop
imag
collect
use
spot
rt
camera
spot
softwar
monensin
treat
sampl
cell
monolay
pretreat
monensin
calbiochem
minut
prior
viru
inocul
fifteen
monensin
ad
bind
media
dmem
infect
media
prevent
low
ph
depend
fusion
activ
ibvbdtt
infect
contrast
sendai
viru
infect
unaffect
monensin
treatment
fig
show
ibvbdtt
infect
cell
sensit
monensin
treatment
concentr
infect
could
restor
monensin
ad
hour
postvir
inocul
data
shown
indic
monensin
indirect
effect
viral
replic
specif
affect
viru
entri
narrow
specif
rout
ibvbdtt
entri
studi
effect
chlorpromazin
ibv
entri
chlorpromazin
induc
clathrin
lattic
assembl
around
endosom
inhibit
protein
bind
cellular
membran
henc
prevent
clathrinco
pit
format
clathrinmedi
endocytosi
infect
cell
ibvbdtt
influenza
viru
strain
atcc
perform
essenti
describ
chlorpromazin
calbiochem
dilut
bind
media
concentr
drug
treatment
follow
viru
infect
perform
figur
show
ibvbdtt
infect
inhibit
chlorpromazin
treatment
dosedepend
manner
howev
control
influenza
viru
remain
unaffect
chlorpromazin
treatment
sinc
influenza
virus
enter
cell
clathrindepend
andindepend
endocyt
pathway
exclud
nonspecif
effect
chlorpromazin
viru
replic
chlorpromazin
ad
hour
postviru
inocul
bypass
effect
ibvbdtt
entri
ibvbdtt
infect
restor
much
nontreat
control
suggest
chlorpromazin
specif
inhibit
ibvbdtt
entri
clathrinmedi
endocyt
pathway
fig
use
drug
monensin
chlorpromazin
screen
ibv
entri
pathway
serv
effect
tool
initi
investig
howev
special
assay
screen
method
target
individu
endocyt
compart
cellular
pathway
requir
draw
definit
conclus
regard
molecular
mechan
ibv
entri
target
cell
coloc
studi
specif
cellular
compart
eg
clathrin
coat
pit
caveolin
earli
late
recycl
endosom
infect
virion
use
panel
antibodi
marker
help
reveal
precis
locat
stage
ibv
entri
also
shown
cholesterol
function
cofactor
fusion
mous
hepat
viru
mhv
therefor
lipid
raft
may
also
play
role
coronaviru
entri
final
domin
neg
protein
small
interf
rna
may
serv
effect
tool
investig
entri
requir
ibv
address
futur
experi
would
like
thank
dr
benjamin
luciomartinez
dr
sy
naqi
provis
virus
antibodi
xiangji
sun
experiment
support
work
support
nih
grant
